Field validation of dietary medication to reduce the severity of Kudoa thyrsites in farmed Atlantic Salmon
Farmed Atlantic Salmon are at risk of infection with Kudoa thyrsites throughout British Columbia, leading to an elevated risk of reduced fillet quality. The cost to the BC farmed Atlantic Salmon industry was over $15 million in 2010, adding to the difficulty for the BC industry to remain competitive in the global salmon market. Early screening of farmed stock is now often used for Kudoa detection. Neither vaccines nor medicines are currently available for the prevention or treatment of the infection. This project will build on the on-going work of the ACRDP project P-11-02-008 "Validation of dietary medication and sterilised seawater to reduce the severity of Kudoa thyrsites in farmed Atlantic Salmon" by adding a validation component based in open netpen production environment. The results will further contribute to the development of novel management strategies for the control of K. thyrsites in farmed Atlantic Salmon.
2011 - 2012
Pacific: Vancouver Island West Coast
- Date modified: